- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Solid Malignancies in United Kingdom
Total 4340 results
-
MedImmune LLCCompletedAdvanced MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Nonhematologic MalignanciesUnited States
-
Mereo BioPharmaICON Clinical ResearchCompletedAdvanced Solid Tumor | Metastatic Solid Tumor | Solid Tumor, AdultUnited States, United Kingdom
-
Gilead SciencesCalifornia Institute for Regenerative Medicine (CIRM)CompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited Kingdom
-
Sumitomo Pharma America, Inc.CompletedCancer, Advanced MalignanciesCanada, United States
-
Memorial Sloan Kettering Cancer CenterWithdrawnHistologically-confirmed MalignanciesUnited States
-
Novartis PharmaceuticalsCompletedA Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic FunctionAdvanced Malignancies | TumorsUnited States
-
Incyte CorporationTerminatedSolid Tumors and Hematologic MalignancyUnited States, Netherlands, Belgium
-
M.D. Anderson Cancer CenterNot yet recruitingMyeloid Malignancies | Lymphodepleting ChemotherapyUnited States
-
University of California, DavisCompletedHematologic MalignanciesUnited States
-
Jazz PharmaceuticalsCompletedAdvanced Solid Tumor | Metastatic Solid Tumor | Urothelial Cancer | Poorly Differentiated Neuroendocrine Carcinomas | Homologous Recombination Deficient-Positive Malignancies AgnosticUnited States
-
Incyte CorporationRecruitingA Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsAdvanced Solid Tumors | Solid Tumors | Metastatic Solid TumorsUnited States, Spain, United Kingdom, France, Italy, Denmark, Switzerland
-
Achilles Therapeutics UK LimitedRecruiting
-
Ono Pharmaceutical Co. LtdTerminatedSolid TumorUnited States, United Kingdom
-
Infinity Pharmaceuticals, Inc.Terminated
-
Hoffmann-La RocheCompletedSolid TumorsKorea, Republic of, Spain, Denmark, France, United Kingdom
-
Beijing InnoCare Pharma Tech Co., Ltd.Active, not recruitingPart 1:r/r B-cell Malignancies | Part 2:B-cell MalignanciesUnited States, Poland, Israel, Ukraine
-
AstraZenecaActive, not recruitingSolid TumorsBelgium, United Kingdom, Switzerland, Australia
-
Boehringer IngelheimActive, not recruitingSolid Tumors, KRAS MutationSpain, United Kingdom, United States, Belgium
-
Regeneron PharmaceuticalsWithdrawnAdvanced MalignanciesUnited States
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of MedicineCompletedMyeloid Hematological MalignanciesUnited States
-
Royal Marsden NHS Foundation TrustPfizer; Roche Pharma AG; Institute of Cancer Research, United KingdomUnknownBreast Cancer | Advanced Solid TumoursUnited Kingdom
-
Incyte CorporationActive, not recruitingB-cell MalignanciesUnited States
-
CelgeneCompletedHematologic Malignancy | Malignant LymphomaUnited States, United Kingdom
-
Gilead SciencesRecruitingSolid TumorKorea, Republic of, Taiwan, Canada, United Kingdom, Spain, United States
-
CelgeneCompletedHematologic Malignancy | Malignant LymphomaUnited States, United Kingdom
-
AstraZenecaCompletedSolid TumoursBelgium, Denmark, France, United Kingdom, Netherlands
-
Incyte CorporationCompleted
-
BicycleTx LimitedRecruitingAdvanced Solid TumorUnited States, United Kingdom
-
AstraZenecaCompletedSolid TumoursDenmark, Belgium, United Kingdom, Netherlands
-
AGC Biologics S.p.A.CompletedHematological MalignanciesItaly, Israel, United Kingdom, Germany, Greece
-
Washington University School of MedicineRecruitingPediatric Hematologic MalignanciesUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Novartis... and other collaboratorsTerminated
-
SCRI Development Innovations, LLCNovartisCompletedAdvanced Malignancies | Refractory MalignancyUnited States
-
Millennium Pharmaceuticals, Inc.TerminatedAdvanced Nonhematological MalignanciesUnited States
-
Affimed GmbHActive, not recruitingAdvanced Solid TumorUnited States, Korea, Republic of, Spain, Germany, United Kingdom
-
Anand B. KarnadCompletedAdvanced B-cell Lymphoid MalignanciesUnited States
-
Regeneron PharmaceuticalsTerminatedAdvanced PD-L1 Positive MalignanciesUnited States
-
Leap Therapeutics, Inc.Cancer Research Institute, New York CityCompletedUnresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor MalignanciesUnited States
-
OncoMed Pharmaceuticals, Inc.Celgene CorporationCompletedLocally Advanced or Metastatic Solid TumorsUnited States, United Kingdom
-
Repare TherapeuticsActive, not recruitingAdvanced Solid TumorUnited States, Canada, Spain, United Kingdom
-
Taiho Oncology, Inc.CompletedAdvanced Solid TumorsUnited States, United Kingdom, Italy
-
Emory UniversityNovartis; CelgeneCompletedNeuroendocrine Tumors | Solid Organ Malignancies | Adenoidcystic CarcinomaUnited States
-
Novartis PharmaceuticalsCompletedA Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic FunctionAdvanced Malignancies | TumorsUnited States
-
Joaquina BarandaActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Cancer | Solid Tumor | Malignant Disease | Relapsed Hematologic MalignancyUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Malignant Solid Neoplasm | Locally Advanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | COVID-19 Infection | Recurrent Hematologic MalignancyUnited States
-
Novartis PharmaceuticalsCompletedHepatocellular Carcinoma (HCC) | Solid MalignanciesUnited States, Germany, Taiwan, Spain, Singapore, France, Japan, Korea, Republic of, Hong Kong, China, Italy
-
Boehringer IngelheimRecruitingSolid TumorsSpain, Japan, United Kingdom, United States
-
Janssen Research & Development, LLCCompletedNeoplasms | Neoplasms, Breast | Neoplasms, Ovarian | Advanced or Refractory Solid MalignanciesUnited States, United Kingdom, Spain, Belgium
-
Novartis PharmaceuticalsCompletedNON-breast HER2+ MalignanciesUnited States, Italy, Korea, Republic of, Japan